Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 258Breast Neoplasms 218Lung Neoplasms 207Glioblastoma 202Head and Neck Neoplasms 193Prostatic Neoplasms 179Squamous Cell Carcinoma of Head and Neck 171Lymphoma 152Rectal Neoplasms 139Esophageal Neoplasms 125Central Nervous System Neoplasms 122Leukemia 111Brain Neoplasms 107Pancreatic Neoplasms 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Gliosarcoma 87Esophageal Squamous Cell Carcinoma 84Sarcoma 82Uterine Cervical Neoplasms 81Neoplasms 81Lymphoma, Follicular 81Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Non-Hodgkin 75Hodgkin Disease 74Glioma 68Burkitt Lymphoma 67Colorectal Neoplasms 66Leukemia, Lymphocytic, Chronic, B-Cell 63Astrocytoma 63Neoplasm Metastasis 60

Interventions

Cisplatin 7Cetuximab 5Drug Therapy 4Radiotherapy 3Resistance Training 2Radiotherapy, Intensity-Modulated 2Nutritional Status 2Hydroxyurea 2Fluorouracil 2Erlotinib Hydrochloride 2Bevacizumab 2zimberelimab 1temsirolimus 1pembrolizumab 1Valproic Acid 1Sirolimus 1Radiation 1Quality of Life 1Psychology, Positive 1Patient Reported Outcome Measures 1Oncolytic Virotherapy 1Molecular Diagnostic Techniques 1Methods 1Metabolic Flux Analysis 1Immunotherapy 1Immunoglobulin G 1Etoposide 1Docetaxel 1Disulfides 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pharyngeal Neoplasms × Radiotherapy × Clear all
NCT01445405 2019-12-17

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
3 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Pharyngeal Neoplasms

NCT00117572 2018-04-09

DeCIDE

University of Chicago

Phase 3 Completed
285 enrolled 22 charts
Head & Neck

Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00462735 2018-03-13

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
33 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡